LysoPC(18:2(9Z,12Z))
|
Basic information |
| Metabolite name | LysoPC(18:2(9Z,12Z)) |
 | N/A |
 |
C04230 |
 |
N/A |
| Synonyms | LysoPC[18:2(9Z,12Z)] |
| No. of studies | 5 |
|
Basic information |
| Metabolite name | LysoPC(18:2(9Z,12Z)) |
| N/A |
|
C04230 |
|
N/A |
| Synonyms | LysoPC[18:2(9Z,12Z)] |
| No. of studies | 5 |
|
Relationship between LysoPC(18:2(9Z,12Z)) and depression (count: 5) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1039 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Down |
| Study M1039 | Type2 | CUMS + high dose of Angelicae Sinensis Radix group vs. CUMS group | Liver | Sprague-Dawley rat | Up |
| Study M1072 | Type1 | CUMS group vs. control group | Faece | Cynomolgus monkey | Down |
| Study M1072 | Type1 | CUMS group vs. control group | Intestine | Cynomolgus monkey | Up |
| Study M210 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M210 | Type2 | CUMS + venlafaxine group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M210 | Type2 | CUMS + curcumin group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M460 | Type1 | depressed group vs. control group | Liver | Kunming mouse | Up |
| Study M681 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M681 | Type2 | CUMS + Chaihu Shu Gan San group vs. CUMS group | Serum | Sprague-Dawley rat | Up |